"Chapter 33: the history of movement disorders" "An evidence-based osteopathic approach to Parkinson disease"
London: Royal College of Physicians "Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease"

بمحض الصدفة.. تقنية جينية تُبشر بطفرة في علاج مرض باركنسون

Mark Hallett; Werner Poewe 13 October 2008.

أسباب و أعراض مرض الباركنسون و المضاعفات الناتجة عنه
Mahlknecht, Philipp; Krismer, Florian; Poewe, Werner; Seppi, Klaus 2017-02-02
علاج مرض باركنسون
"The non-motor and non-dopaminergic fratures of PD"
مرض باركنسون
London: Royal College of Physicians
London: Royal College of Physicians GBD 2015 Mortality and Causes of Death, Collaborators
"Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease an evidence-based review : report of the Quality Standards Subcommittee of the American Academy of Neurology" Journal of the American College of Nutrition

الأعراض الأساسية لمرض باركنسن

"Cellular replacement therapy for Parkinson's disease — where we are today? Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A 2010.

بحث عن مرض باركنسون
"Effectiveness of acupuncture for Parkinson's disease: a systematic review"
علاج مرض باركنسون بالغذاء والأعشاب
Mann, Tanveer 8 December 2016
مرض الباركنسون : ما هي الأسباب و ما هو العلاج
"Parkinson's disease psychosis 2010: A review article"
"The history of dopamine and levodopa in the treatment of Parkinson's disease" "Occupational therapy for patients with Parkinson's disease"
Schwarz, ST; Afzal, M; Morgan, PS; Bajaj, N; Gowland, PA; Auer, DP 2014 "Resistance Training and Gait Function in Patients with Parkinson's Disease"

أمراض الجهاز العصبي

"Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial".

3
مرض الباركنسون ومراحل تطوره
; Berg, Daniela; Stern, Matthew; Poewe, Werner; Olanow, C
هل يبدأ مرض باركنسون في الأمعاء؟
23 Suppl 3 : S548—59
بحث عن مرض باركنسون
"L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent"